Leonardo A. Rodríguez-López

Leonardo A. Rodríguez-López


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Archives of Medical Research
Verified
Journal Article
Closed access
AVAriana Vargas-Castillo
Ariana Vargas-Castillo
RFRebeca Fuentes-Romero
Rebeca Fuentes-Romero
LRLeonardo A. Rodríguez-López
Leonardo A. Rodríguez-López
NTNimbe Torres
Nimbe Torres
ATArmando Tovar
Armando Tovar

25 March 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Ivan Torre-VillalvazoIvan Torre-Villalvazo
Ivan Torre-Villalvazo
ABAna E. Bunt
Ana E. Bunt
GAGabriela Alemán
Gabriela Alemán
CMClaudia Cecilia Mota
Claudia Cecilia Mota
ADAndrea Díaz-Villaseñor
Andrea Díaz-Villaseñor
ATArmando Tovar
Armando Tovar

Verified
Journal Article
Open access
PDF file
Claudia Delgadillo PugaClaudia Delgadillo Puga
Claudia Delgadillo Puga
LNLilia G. Noriega
Lilia G. Noriega
AMAurora M. Morales-Romero
Aurora M. Morales-Romero
ACAntonio Nieto Camacho
Antonio Nieto Camacho
OGOmar Granados-Portillo
Omar Granados-Portillo
Ivan Torre-VillalvazoIvan Torre-Villalvazo
Ivan Torre-Villalvazo
Goat’s milk is a rich source of bioactive compounds (peptides, conjugated linoleic acid, short chain fatty acids, monounsaturated and polyunsaturated fatty acids, polyphenols such as phytoestrogens and minerals among others) that exert important health benefits. However, goat’s milk composition depends on the type of food provided to the animal and thus, the abundance of bioactive compounds in milk depends on the dietary sources of the goat feed. The metabolic impact of goat milk rich in bioactive compounds during metabolic challenges such as a high-fat (HF) diet has not been explored. Thus, we evaluated the effect of milk from goats fed a conventional diet, a conventional diet supplemented with 30% Acacia farnesiana (AF) pods or grazing on metabolic alterations in mice fed a HF diet. Interestingly, the incorporation of goat’s milk in the diet decreased body weight and body fat mass, improved glucose tolerance, prevented adipose tissue hypertrophy and hepatic steatosis in mice fed a HF diet. These effects were associated with an increase in energy expenditure, augmented oxidative fibers in skeletal muscle, and reduced inflammatory markers. Consequently, goat’s milk can be considered a non-pharmacologic strategy to improve the metabolic alterations induced by a HF diet. Using the body surface area normalization method gave a conversion equivalent daily human intake dose of 1.4 to 2.8 glasses (250 mL per glass/day) of fresh goat milk for an adult of 60 kg, which can be used as reference for future clinical studies.

31 May 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Claudia Delgadillo PugaClaudia Delgadillo Puga
Claudia Delgadillo Puga
Ivan Torre-VillalvazoIvan Torre-Villalvazo
Ivan Torre-Villalvazo
LNLilia G. Noriega
Lilia G. Noriega
LRLeonardo A. Rodríguez-López
Leonardo A. Rodríguez-López
GAGabriela Alemán
Gabriela Alemán
LCLuis Cisneros-Zevallos
Luis Cisneros-Zevallos
Pecans (Carya illinoinensis) are considered a functional food due to the high content of polyunsaturated fatty acids, dietary fiber and polyphenols. To determine the effect of whole pecans (WP) or a pecan polyphenol (PP) extract on the development of metabolic abnormalities in mice fed a high-fat (HF) diet, we fed C57BL/6 mice with a Control diet (7% fat), HF diet (23% fat), HF containing 30% WP or an HF diet supplemented with 3.6 or 6 mg/g of PP for 18 weeks. Supplementation of an HF diet with WP or PP reduced fat mass, serum cholesterol, insulin and HOMA-IR by 44, 40, 74 and 91%, respectively, compared to the HF diet. They also enhanced glucose tolerance by 37%, prevented pancreatic islet hypertrophy, and increased oxygen consumption by 27% compared to the HF diet. These beneficial effects were associated with increased thermogenic activity in brown adipose tissue, mitochondrial activity and AMPK activation in skeletal muscle, reduced hypertrophy and macrophage infiltration of subcutaneous and visceral adipocytes, reduced hepatic lipid content and enhanced metabolic signaling. Moreover, the microbial diversity of mice fed WP or PP was higher than those fed HF, and associated with lower circulating lipopolysaccharides (~83–95%). Additionally, a 4-week intervention study with the HF 6PP diet reduced the metabolic abnormalities of obese mice. The present study demonstrates that WP or a PP extract prevented obesity, liver steatosis and diabetes by reducing dysbiosis, inflammation, and increasing mitochondrial content and energy expenditure. Pecan polyphenols were mainly condensed tannin and ellagic acid derivatives including ellagitannins as determined by LC-MS. Herein we also propose a model for the progression of the HF diet-mediated metabolic disorder based on early and late events, and the possible molecular targets of WP and PP extract in preventive and intervention strategies. The body surface area normalization equation gave a conversion equivalent to a daily human intake dose of 2101–3502 mg phenolics that can be obtained from 110–183 g pecan kernels/day (22–38 whole pecans) or 21.6–36 g defatted pecan flour/day for an average person of 60 kg. This work lays the groundwork for future clinical studies.

30 July 2021 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
LRLeonardo A. Rodríguez-López
Leonardo A. Rodríguez-López
Ivan Torre-VillalvazoIvan Torre-Villalvazo
Ivan Torre-Villalvazo
GAGabriela Aleman-Escondrillas
Gabriela Aleman-Escondrillas
AFAdriana Flores-López
Adriana Flores-López
MGMartha Guevara-Cruz
Martha Guevara-Cruz
ATArmando Tovar
Armando Tovar

5 June 2021 in Materials
Verified
Journal Article
Open access
PDF file
YRYolik Ramírez-Marín
Yolik Ramírez-Marín
DADavid Abad
David Abad
MUMartha Ustarroz-Cano
Martha Ustarroz-Cano
NPNorma S. Pérez-Gallardo
Norma S. Pérez-Gallardo
LVLorena Villafuerte
Lorena Villafuerte
DGDavid Giraldo
David Giraldo
Reconstruction of bile ducts damaged remains a vexing medical problem. Surgeons have few options when it comes to a long segment reconstruction of the bile duct. Biological scaffolds of decellularized biliary origin may offer an approach to support the replace of bile ducts. Our objective was to obtain an extracellular matrix scaffold derived from porcine extrahepatic bile ducts (dECM-BD) and to analyze its biological and biochemical properties. The efficiency of the tailored perfusion decellularization process was assessed through histology stainings. Results from 4’-6-diamidino-2-phenylindole (DAPI), Hematoxylin and Eosin (H&E) stainings, and deoxyribonucleic acid (DNA) quantification showed proper extracellular matrix (ECM) decellularization with an effectiveness of 98%. Immunohistochemistry results indicate an effective decrease in immunogenic marker as human leukocyte antigens (HLA-A) and Cytokeratin 7 (CK7) proteins. The ECM of the bile duct was preserved according to Masson and Herovici stainings. Data derived from scanning electron microscopy (SEM) and thermogravimetric analysis (TGA) showed the preservation of the dECM-BD hierarchical structures. Cytotoxicity of dECM-BD was null, with cells able to infiltrate the scaffold. In this work, we standardized a decellularization method that allows one to obtain a natural bile duct scaffold with hierarchical ultrastructure preservation and adequate cytocompatibility.